New Search

If you are not happy with the results below please do another search

38 search results for:

11

How do companies get value out of AI in Medical Affairs?

/0 Comments/in
How do companies get value out of AI in Medical Affairs? With budget season upon most organizations, the questions about where to invest and how to deliver growth results or realize efficiencies are top of mind. Reflecting on 18 months with generative AI solutions and continued exchanges and discussions about yet more transformative potential of [...]
12

Early Diagnosis in Rare Diseases: The Power of Technology

/0 Comments/in
Early Diagnosis in Rare Diseases: The Power of Technology In the complex world of rare diseases, early diagnosis is both critical and challenging. With over 7,000 known rare diseases affecting millions worldwide, the need for innovative diagnostic approaches has never been greater. At FFI Ventures, we collaborate closely with life-science industry partners to leverage cutting-edge [...]
14

Boost your gen AI ROI: Scaling AI projects multiplies returns

/0 Comments/in
Boost Your ROI: Scaling AI Projects Multiplies Returns Successfully scaling generative AI projects can significantly boost your ROI. While initial returns from pilot projects may be limited, scaling these initiatives can yield three times the return compared to those that never move beyond the pilot stage. For every dollar invested in AI, companies see an [...]
15

ONERAY.AI Capability Update: Document Summarization & Discussion

/0 Comments/in
ONERAY.AI capability update Exciting update! Our private Hashtag#generativeAI solution OneRay.AI, co-created with Pharma and Biotech partners just released a capability update. This state-of-the-art tool now offers ad-hoc summarization and discussion for up to 5 documents simultaneously in a secure, Pharma-compliant environment. It supports multiple formats, including images and graphs, and validates with Hashtag#Veeva and approved [...]
16

Competencies that drive impact in Rare Diseases

/0 Comments/in
Competencies that drive impact in Rare Disease We contribute to the management of rare diseases by fostering collaboration between life-science companies, patients, and support networks at global scale. The journey to diagnose a rare disease often spans 6 to 8 years due to the complexity and rarity of these conditions, often compounded by misdiagnoses and [...]
17

FFI generative AI framework & key services

/0 Comments/in
FFI generative AI framework & key services Ready to unlock the impact of #GenAI this summer? With over 18 months of diverse experience, FFI can rapidly support your organization in maximizing AI value creation. From strategy and governance to execution, we guide you through every step - including setting up your custom, private #GenerativeAI environment. [...]
18

Maximizing ROI in Pharma: A Deep Dive into AI Use Case Prioritization

/0 Comments/in
Maximizing ROI in Pharma: A Deep Dive into AI Use Case Prioritization The prioritization grid for generative AI use cases in the pharmaceutical industry provides a comprehensive overview of various use cases FFI-Ventures is working on today and within the last 18 months. The grid outlines the potential business impact, and technical feasibility of use [...]
19

FFI has a broad spectrum of capabilities

/0 Comments/in
FFI has broad spectrum of capabilities We're talking a lot about Hashtag#genAI but Hashtag#FFI goes beyond AI scaling in Pharma. We offer a unique blend of global and local expertise, combining innovative strategies with practical execution. Across Pharma, Medtech & Biotech functions, our approach and team delivers significant results & value-add. Discover how FFI can [...]
20

Ramping-up private gen AI within Pharma and Medtech organizations

/0 Comments/in
Ramping-up private gen AI within Pharma and Medtech organizations Especially for medical and commercial organizations, the integration of private bespoke generative AI solutions is becoming a game-changer. This blog post explores the strategic approach to implementing tailored AI solutions in the pharma industry, highlighting how FFI-Ventures can support organizations throughout this transformative journey. The step-wise [...]